Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion type Assertion NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_head.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion description "[Furthermore, combinations of PT-20210A or FVL with PAI-1 (4G/4G) were significantly more frequent in APS patients (5.8%) than in normal controls (0.5%, p=0.016).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_provenance.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion evidence source_evidence_literature NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_provenance.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion SIO_000772 11454529 NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_provenance.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion wasDerivedFrom befree-2016 NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_provenance.
- NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_assertion wasGeneratedBy ECO_0000203 NP323935.RAIR6tBtUWO6K583ygaKNIEInebi_0Q7XBIlT0kAwXxSk130_provenance.